Bloomberg finds black mold, bugs at Chinese GLP-1 ingredient plants
The report centers on facilities supplying active ingredients used by US compounders of semaglutide and tirzepatide copies.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 15 07:30 ETSource: Bloomberg
The wire
- 01Bloomberg reported unsanitary conditions, including black mold and insects, at Chinese plants producing GLP-1 active pharmaceutical ingredients for compounding.
- 02Compounding pharmacies and telehealth sellers that source overseas API face renewed scrutiny over supplier qualification and incoming testing.
- 03Specific firms, volumes and any resulting FDA import action were not detailed here; readers should watch for import alerts or warning letters.
From the source
Read at bloomberg.comBlack Mold, Bugs Found at Chinese Plants Making GLP-1 Compounding Agents
